Reversal of P-glycoprotein-mediated multidrug resistance by natural N-alkylated indole alkaloid derivatives in KB-ChR-8-5 drug-resistant cancer cells

Multidrug resistance (MDR) remains a significant challenge in cancer chemotherapy due to the overexpression of ATP-binding cassette drug-efflux transporters, namely P-glycoprotein (P-gp)/ATP-binding cassette subfamily B member 1. In this study, derivatives of N-alkylated monoterpene indole alkaloids...

Full description

Saved in:
Bibliographic Details
Published inJournal of biochemical and molecular toxicology Vol. 37; no. 9; p. e23421
Main Authors Bharathiraja, Pradhapsingh, Cardoso, David S P, Rajendra Prasad, N, Mulhovo, Silva, Lakra, Deepa S, Ferreira, Maria-José U
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.09.2023
Subjects
Alkaloids
Alkylation
Apoptosis
ATP
Binding
Cancer
Caspase-3
Cassettes
Cell survival
Chemotherapy
Colchicine
Doxorubicin
Efflux
Glycoproteins
Indoles
Multidrug resistance
Multidrug resistant organisms
Nuclear transport
Synergism
Translocation
P-glycoprotein
multidrug resistance
apoptosis
chemosensitization
monoterpene indole alkaloids
Online AccessGet full text

Cover

More Information
Summary:Multidrug resistance (MDR) remains a significant challenge in cancer chemotherapy due to the overexpression of ATP-binding cassette drug-efflux transporters, namely P-glycoprotein (P-gp)/ATP-binding cassette subfamily B member 1. In this study, derivatives of N-alkylated monoterpene indole alkaloids such as N-(para-bromobenzyl) (NBBT), N-(para-methylbenzyl) (NMBT), and N-(para-methoxyphenethyl) (NMPT) moieties were investigated for the reversal of P-gp-mediated MDR in drug-resistant KB colchicine-resistant 8-5 (KB-ChR-8-5) cells. Among the three indole alkaloid derivatives, the NBBT exhibited the highest P-gp inhibitory activity in a dose-dependent manner. Further, it significantly decreased P-gp overexpression by inactivating the nuclear translocation of the nuclear factor kappa B p-50 subunit. In the cell survival assay, doxorubicin showed 6.3-fold resistance (FR) in KB-ChR-8-5 cells compared with its parental KB-3-1 cells. However, NBBT significantly reduced doxorubicin FR to 1.7, 1.3, and 0.4 and showed strong synergism with doxorubicin for all the concentrations studied in the drug-resistant cells. Furthermore, NBBT and doxorubicin combination decreased the cellular migration and showed increased apoptotic incidence by downregulating Bcl-2, then activating BAX, caspase 3, and p53. The present findings suggest that NBBT could be a lead candidate for the reversal of P-gp- mediated multidrug resistance in cancer cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1095-6670
1099-0461
DOI:10.1002/jbt.23421